(Q47998008)

English

Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics

scientific article published on 12 September 2017

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

1 reference

based on heuristic

inferred from title

author name string

Dominic Pilon

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Matthew Alcusky

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Yongling Xiao

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Philippe Thompson-Leduc

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Marie-Hélène Lafeuille

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Patrick Lefebvre

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Carmela Benson

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

language of work or name

0 references

publication date

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Journal of Medical Economics

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

21

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

135-143

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Schizophrenia: a systemic disorder

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

The environment and susceptibility to schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Role of dopamine D(2) receptors for antipsychotic activity

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Schizophrenia relapse, patient considerations, and potential role of lurasidone

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Towards a pragmatic and operational definition of relapse in schizophrenia: A Delphi consensus approach

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Partial compliance in schizophrenia and the impact on patient outcomes

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Medication adherence of individuals with a first episode of psychosis

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Efficacy and safety of long acting injectable atypical antipsychotics: a review

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Dose and dosing frequency of long-acting injectable antipsychotics: a systematic review of PET and SPECT data and clinical implications

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Dose equivalents for second-generation antipsychotics: the minimum effective dose method

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Outpatient antipsychotic treatment and inpatient costs of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F13696998.2017.1379413

21 January 2018

Identifiers

10.1080/13696998.2017.1379413

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/28895766

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47998008&oldid=2180993085"